VBID Center

Updates to CMS' Medicare Advantage (MA) Value-Based Insurance Design (VBID) model broaden the scope of the existing model by testing a wide range of MA service delivery and/or payment approaches.

A literature review published in the July issue of Health Affairs concluded that value-based insurance design (VBID) programs that reduced consumer cost-sharing for prescription drugs led to improved medication adherence at no added cost.

Value-based insurance design (VBID) principles were highlighted at 2 congressional hearings as a promising reform to high-deductible health plans (HDHPs).

A new rule from CMS for 2019 would allow for more flexibility in benefit design for Medicare Advantage enrollees with specified chronic conditions.

As high-deductible health plans (HDHPs) grow in popularity, the University of Michigan Center for Value-Based Insurance Design is advocating for a clinically nuanced alternative to the traditional HDHP.

Incorporating the principles of value-based insurance design (VBID) can help prevent the negative effects of outcomes-oriented contracting, such as cost-related nonadherence.

Broad bipartisan and multi-stakeholder support of VBID has stemmed from its applicability to a wide range of healthcare issues and its potential to reduce overall healthcare expenditures while improving health outcomes.

Precision co-pay assistance programs have the potential to improve prescription affordability while increasing efficiency of limited patient assistance funds.

In 2017, value-based insurance design was 1 of the few healthcare concepts that maintained consistent bipartisan support. Here is a look at progress made in value-based reform using VBID concepts.

One way to improve healthcare quality and efficiency and reduce the use of unnecessary care is to apply the principles of value-based insurance design, which aligns patients’ out-of-pocket costs with the value of services.

CMS' update to the Medicare Advantave Value-Based Insurance Design Model, demonstrate CMS’ continued commitment to expanding the demonstration and allowing participating plans more flexibility for customized benefit designs.

A recently remeleased rule proposal for Medicare Advantage would give plans greater flexibiilty around the uniformity requirement and allow for the implementation of value-based insurance design principles.

A campaign to cut low-value clinical services has identified the top 5 based on cost, harm, and prevalence that can be targeted for reduction.

When Connecticut was facing a projected budget gap of $3.8 billion, the governor's office and a coalition of unions considered how to make changes to the state health plan in order to mitigate the shortfall.

As health reform discussions progress, influential stakeholders have urged policy makers to consider increasing the flexibility of health savings account—eligible high-deductible health plans.

The University of Michigan Center for Value-Based Insurance Design (V-BID) celebrated significant initiative milestones in 2016.

There has been increased bipartisan support around the expanded role of value-based insurance design.

Clinical nuance is one of the core tenets of value-based insurance design, which is one possible solution to alleviate the financial burden Americans face as they are asked to pay a greater percentage of their healthcare expenditures.

In current Medicare benefit designs, out-of-pocket costs do not reflect the expected clinical benefit or value of care. Research indicates that increasing patient cost sharing not only reduces the use of non-essential care, but also reduces the utilization of essential care.

The use of low-value care and the associated cost is a significant concern in the US healthcare system. However, solutions to measure, identify, and eliminate low-value care are challenging and complex.

High-deductible health plans paired with a tax-free health savings account represent a growing percentage of plans across the health insurance landscape.

Access to, and levels of spending on, prescription drugs has become an important public policy issue. The development and implementation of patient-centered solutions that allow access to medications at an affordable cost are of critical importance.